ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,015Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 1125

$657K Total Retail Price of All Prescriptions

Rank: 277 out of 1125

511 Patients Receiving at Least One Drug in Part D
48% Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

74% of this provider’s 511 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 3,589 1,601 372 S3 1 1
ALPRAZOLAM 1,705 874 184 B 2 16
DIAZEPAM 481 158 54 B 3 37
GABAPENTIN 349 138 83 4 10
LEVOTHYROXINE SODIUM 348 203 64 5 3
LISINOPRIL 331 175 77 6 2
MELOXICAM 328 139 132 7 25
CLONAZEPAM 320 96 43 B 8 32
ZOLPIDEM TARTRATE 291 168 44 9 33
AMLODIPINE BESYLATE 281 197 67 10 6
LYRICA 279 136 42 11 82
SIMVASTATIN 259 125 57 12 5
TIZANIDINE HCL 257 126 85 13 74
CLOPIDOGREL 246 159 42 14 15
OMEPRAZOLE 245 132 52 15 4
FUROSEMIDE 241 145 66 16 7
CYMBALTA 217 100 66 17 45
POTASSIUM CHLORIDE 203 136 53 18 14
ATENOLOL 202 93 45 19 21
CITALOPRAM HBR 195 83 57 20 19
RANITIDINE HCL 189 90 48 21 24
METFORMIN HCL 186 97 48 22 8
MONTELUKAST SODIUM 184 121 44 23 35
DICLOFENAC SODIUM 179 89 71 24 80
NEXIUM 177 121 29 25 20
CLONIDINE HCL 170 89 42 26 58
BUMETANIDE 165 100 40 27 121
IBUPROFEN 162 68 55 28 65
METOPROLOL TARTRATE 153 107 33 29 11
ALLOPURINOL 136 96 27 30 40
HYDROCHLOROTHIAZIDE 129 89 26 31 12
ROPINIROLE HCL 128 66 32 32 75
PROAIR HFA 117 73 26 33 39
CYCLOBENZAPRINE HCL 112 34 46 R 34 73
PROMETHAZINE HCL 106 48 37 R 35 72
LORAZEPAM 101 64 22 B 36 30
METOLAZONE 97 73 32 37 210
ATORVASTATIN CALCIUM 95 56 21 38 9
AZITHROMYCIN 95 44 74 38 47
SPIRONOLACTONE 92 57 19 40 78
PREDNISONE 86 45 39 41 44
LOSARTAN POTASSIUM 86 41 18 41 23
AMITRIPTYLINE HCL 83 48 24 R 43 51
TRAMADOL HCL 77 66 17 44 31
TEMAZEPAM 74 35 19 B 45 100
DONEPEZIL HCL 72 67* 11 46 42
GLIPIZIDE 69 44 25 47 64
METOPROLOL SUCCINATE 69 46 16 47 17
CIPROFLOXACIN HCL 68 45 48 49 68
SERTRALINE HCL 67 28 14 50 22
SYNTHROID 62 35 13 51 71
PRAVASTATIN SODIUM 59 <11 <11 52 13
MECLIZINE HCL 59 47 22 52 115
ADVAIR DISKUS 58 27 13 54 61
PREMARIN 56 25 12 R 55 156
CELEBREX 54 19 11 56 83
PANTOPRAZOLE SODIUM 54 41 17 56 27
METOCLOPRAMIDE HCL 54 25 17 56 126
CARVEDILOL 53 24 11 59 26
BACLOFEN 52 19 12 60 116
TRAZODONE HCL 51 33 12 61 36
CARISOPRODOL 51 <11 <11 R 61 175
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.